Alpha Tau Medical Ltd-cl A (DRTS) Technical Analysis
$3.170%
Market is closed - opens 7 PM, 07 Jul 2025
Insights
- Alpha Tau Medical-cl A is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Alpha Tau Medical-cl A stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Alpha Tau Medical-cl A stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Alpha Tau Medical-cl A stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 61.95 | Sell |
Stochastic | 80.0, 79.73 | Neutral |
Ultimate Oscillator | 50.5 | Neutral |
Stochastic Relative Strength Index | 100.0, 92.88 | Neutral |
Moving Average Convergence Divergence | 0.05, 0.04 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 3.04 | Buy |
20 | 3.03 | Buy |
50 | 2.92 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 3.08 | Buy |
20 | 3.03 | Buy |
50 | 2.95 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 3.05 | Neutral |
20 | 3.04 | Neutral |
50 | 2.96 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 3.13 | Buy |
20 | 3.1 | Buy |
50 | 3.02 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 3.16 | Buy |
20 | 3.11 | Sell |
50 | 3.14 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 3.37 |
Resistance L2 | 3.3 |
Resistance L1 | 3.24 |
Pivot Point | 3.17 |
Support L1 | 3.11 |
Support L2 | 3.04 |
Support L3 | 2.98 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.